Preclinical evaluation of coronary stents: focus on safety issues.
de Prado AP, Perez-Martinez C, Cuellas C, Gonzalo-Orden JM, Diego A, Regueiro M, Martinez-Fernandez B, Altonaga JR, Marin Francisco JG, Fernandez-Vazquez F.
de Prado AP, et al.
Curr Vasc Pharmacol. 2013 Jan;11(1):74-99.
Curr Vasc Pharmacol. 2013.
PMID: 22724463
Review.
The development and improvement of drug eluting stents (DES) have lowered the incidence of restenosis to one-digit figures. In the search for a superior efficacy, animal models have played a key role. ...In a back-to-bench step, some data from animal models helped t …
The development and improvement of drug eluting stents (DES) have lowered the incidence of restenosis to one-digit figures. In …